Abstract:BACKGROUND: Peutz-Jeghers syndrome (PJS) is a clinically rare disease with pigmented spots on the lips and mucous membranes and extremities, scattered gastrointestinal polyps, and susceptibility to tumors as clinical manifestations. Effective preventive and curative methods are still lacking. Here we summarize our experience with 566 Chinese patients with PJS from a Chinese medical center with regard to the clinical features, diagnosis, and treatment.AIM: To explore the clinical features, diagnosis, and treatment of PJS in a Chinese medical center.METHODS: The diagnosis and treatment information of 566 cases of PJS admitted to the Air Force Medical Center from January 1994 to October 2022 was summarized. A clinical database was established covering age, gender, ethnicity, family history, age at first treatment, time and sequence of appearance of mucocutaneous pigmentation, polyp distribution, quantity, and diameter, frequency of hospitalization, frequency of surgical operations, etc. The clinical data was retrospectively analyzed using SPSS 26.0 software, with P < 0.05 considered statistically significant.RESULTS: Of all the patients included, 55.3% were male and 44.7% were female. Median time to the appearance of mucocutaneous pigmentation was 2 years, and median time from the appearance of mucocutaneous pigmentation to the occurrence of abdominal symptoms was 10 years. The vast majority (92.2%) of patients underwent small bowel endoscopy and treatment, with 2.3% having serious complications. There was a statistically significant difference in the number of enteroscopies between patients with and without canceration (P = 0.004, Z = -2.882); 71.2% of patients underwent surgical operation, 75.6% of patients underwent surgical operation before the age of 35 years, and there was a statistically significant difference in the frequency of surgical operations between patients with and without cancer (P = 0.000, Z = -5.127). At 40 years of age, the cumulative risk of intussusception in PJS was approximately 72.0%, and at 50 years, the cumulative risk of intussusception in PJS was approximately 89.6%. At 50 years of age, the cumulative risk of cancer in PJS was approximately 49.3%, and at 60 years of age, the cumulative risk of cancer in PJS was approximately 71.7%.CONCLUSION: The risk of intussusception and cancer of PJS polyps increases with age. PJS patients ≥ 10 years old should undergo annual enteroscopy. Endoscopic treatment has a good safety profile and can reduce the occurrence of polyps intussusception and cancer. Surgery should be conducted to protect the gastrointestinal system by removing polyps.

Peutz-Jeghers syndrome without STK11 mutation may correlate with less severe clinical manifestations in Chinese patients

Clinical Characteristics and Stk11 Gene Mutations in Chinese Children with Peutz-Jeghers Syndrome

Mutations Analysis Ofstk 11 Gene in Chinese Families with Peutz-Jeghers Syndrome

Analysis of STK11 gene variant in five Chinese patients with Peutz-Jeghers syndrome

A Clinical and Molecular Genetic Study in 11 Chinese Children With Peutz-Jeghers Syndrome.

Must Peutz-Jeghers syndrome patients have the LKB1/STK11 gene mutation? A case report and review of the literature

Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome

Mutation Characteristic of STK_(11) Gene in Chinese with Peutz-Jeghers Syndrome

Genetic variation at a splicing branch point in intron 7 of STK11: a rare variant decreasing its expression in a Chinese family with Peutz-Jeghers syndrome

Changes of gut microbiota and short chain fatty acids in patients with Peutz-Jeghers syndrome

Clinical Characteristics And Genetic Analysis Of Gene Mutations In A Chinese Pedigree With Peutz-Jeghers Syndrome

High Risk and Early Onset of Cancer in Chinese Patients with Peutz-Jeghers Syndrome

A De Novo Mutation of STK11 Gene in a Chinese Patient with Peutz–Jeghers Syndrome

Exome Sequencing Revealed Novel Germline Mutations in Chinese Peutz–Jeghers Syndrome Patients

[Analysis of STK11 Gene Variants among 64 Patients with Peutz-Jeghers Syndrome].

Detection and analysis of common pathogenic germline mutations in Peutz-Jeghers syndrome

Genetic Screening and Analysis of Lkb1 Gene in Chinese Patients with Peutz-Jeghers Syndrome

Three Novel Mutations of STK11 Gene in Chinese Patients with Peutz–Jeghers Syndrome

Clinical features, diagnosis, and treatment of Peutz-Jeghers syndrome: Experience with 566 Chinese cases

One novel deletion and one splicing mutation of the LKB1 gene in two Chinese patients with Peutz-Jeghers syndrome.

Immune profiling of premalignant lesions in patients with Peutz-Jeghers syndrome